ARCHIVES

Phase II Elotuzumab Study Demonstrates 33 Months PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Upton Leaning to New Division for Centers, Organ Sites, Education

August 25, 1978

Boston Study Finds Adenocarcinoma Of Esophagus Increasing

July 14, 1989

NIH Inquiry Finds No Impropriety In Treatment of Teddy DeVita

April 9, 1976

Some Children With Hodgkin’s Disease Can Reduce Or Skip Radiation, Study Finds

October 29, 2004

Guidelines Adopted For Pathology Review

February 22, 1980

Addition of Immune Stimulant To Yervoy Therapy Increases Overall Survival, Study Says

November 28, 2014